Demoxoft Solution
Product information
DEMOXOFT SOLUTION is a product designed for professional care of irritated skin of the eyelids. It contains delicate, specially selected surfactants.
Indications
- Recommended for itching and irritation of the eyelids
- Removes impurities and secretions from the eyelids and their edges.
How it works
Demoxoft solution, which contains specially selected ingredients, moisturizes sensitive skin of the eyelids, eliminates the unpleasant feeling associated with dryness and damage to the skin, as well as it effectively stimulates regeneration processes. Aloe vera decreases itching and burning associated with inflammation. D-panthenol (provitamin B5) gives the skin elasticity and reduces irritation, whereas hyaluronic acid with Fucogelem® create a protective coating and provide comprehensive moisturizing of the irritated skin. In addition, Olivem®300 component - a natural emollient based on the valuable properties of olive oil - makes the skin soft.
Advantages
- Unique formulation designed for professional security and care of eyelids in patients with blepharitis
Innovative composition developed in cooperation with the Polish research center - Positive results of use of Demoxoft preparations as regards to objective and subjective symptoms in patients with blepharitis caused by demodex [1]
- Ophthalmologist tested
Ingedients
Active ingredients:
- D-pantenol
- Hyaluronic acid
- Aloe vera
- Fucogel®
Olivem® 300
The product is hypoallergenic.
Instructions for use and the contents
Soak cosmetic pads with the solution and cleanse the eyelids during the morning eyelid hygiene. It is desirable to use a separate cosmetic pad for each eye. The formulation does not require rinsing.
Eye wash with DEMOXOFT solution formulation can be repeated several times a day. DEMOXOFT can be used regardless of the application of DEMOXOFT Lipogel to protect and care for the skin of the eyelids and face.
Packaging: 100 ml
[1] Demodex - results presented at a scientific congress of The Association for Research in Vision and Ophthalmology ARVO, 3-8.05.2014, Orlando, USA